Home  >  News
Veterinary + Font Resize -

Sonoma Pharma begins commercialization of MicrocynAH animal healthcare products in Japan

Petaluma, California
Friday, September 15, 2017, 13:00 Hrs  [IST]

Sonoma Pharmaceuticals, a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced tissue care, announced the commercialization of the MicrocynAH family of animal healthcare products in Japan.  

Approved as a health care product for use by both pet owners and veterinarians, the MicrocynAH products are being exclusively distributed in Japan by World Pet Care Products Company, Ltd., under the direction of the master Asian distributor, Petagon Limited.  World Pet Care Products specializes in pet health care and consultancy services contributing to improved quality of life in pets as well as human-animal bonding.

"It is our great honor to be afforded this wonderful opportunity to market MicrocynAH products in the Japanese market.  Based upon my previous experience in establishing Hill's products as the market leader in the Japanese pet food market, it is similarly my goal to establish MicrocynAH products as the Japanese market leader in topical wound and skin care products," said Yoshio Koshimura, chairman and CEO of World Pet Care Products, Ltd.

MicrocynAH products available include:  Wound & Skin Care Spray, Wound & Skin Care Hydrogel, Ophthalmic Gel, Eye & Ear Wash, Anti-Itch Gel Spray with Dimethicone and Hot Spot Gel Spray with Dimethicone.  The products are well suited for dogs, cats, horses, birds, reptiles and other animals, both large and small.  They are based upon the clinically proven Micrcocyn Technology with 53 patents, 30-plus clinical studies and 16 FDA clearances. This line of products has successfully treated over ten million patients worldwide.

"It is an esteemed honor and privilege to partner with both Petagon Limited and World Pet Care Products in our efforts to broadly introduce the MicrocynAH products to both pet owners and veterinarians throughout Japan.   As with our successes in establishing MicrocynAH as a market leader in the U.S., Hong Kong, China, the Middle East and Europe, our quest in Japan is to establish ourselves as a market leader there as well," said Bruce Thornton, senior vice president of international sales for Sonoma Pharmaceuticals.  "This partnership and the cash it generates is a solid step towards our company-wide plan to breakeven next calendar year."

MicrocynAH will be available to Japanese retailers and veterinarians beginning in early November, to be launched in conjunction with an industry presentation at the University of Tokyo by Dr. Chelsea Tripp, DVM, MS, DACVIM and a board-certified veterinary oncologist.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
duphat_150x60
IPJPI18_150x60en_2018
PHARMACONNECT_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |